슬관절 임플란트 시장 : 수술 유형별, 임플란트 유형별, 고정 방법별, 소재별, 기술별, 최종 사용자별 시장 예측(2026-2032년)

The Knee Implant Market is projected to grow by USD 11.44 billion at a CAGR of 6.86% by 2032.

Knee Implant Market Introduction

The knee implant market is anchored by the global clinical burden of knee osteoarthritis, trauma, inflammatory joint disease, and revision arthroplasty. The World Health Organization reports that osteoarthritis affected approximately 528 million people in 2019, with the knee representing the most frequently affected joint site; this creates sustained demand for total knee replacement, partial knee replacement, revision implants, and enabling technologies.

Market momentum is supported by population aging, higher obesity prevalence, improved access to orthopedic care, and rising patient expectations for mobility and pain relief. At the same time, buyers are scrutinizing implant survivorship, procedural efficiency, infection control, and total episode-of-care cost, making evidence-backed knee implant systems, surgeon training, and post-operative outcomes central to competitive differentiation.

Transformative Shifts in the Knee Implant Landscape

The knee implant landscape is shifting from volume-driven arthroplasty toward value-based reconstruction. Hospitals and ambulatory surgery centers are adopting standardized care pathways, enhanced recovery protocols, and digital preoperative planning to reduce length of stay while maintaining clinical quality. National joint registries in countries such as the United Kingdom, Australia, and Sweden continue to influence purchasing by highlighting revision rates and long-term implant performance.

Technology is also transforming product strategy. Robotic-assisted knee replacement, patient-specific instrumentation, cementless fixation, porous coatings, highly cross-linked polyethylene, and anatomically optimized designs are being evaluated against traditional implants through real-world evidence. Manufacturers that combine durable implant portfolios with workflow efficiency and data capture are better positioned as orthopedic providers focus on reproducible outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly shaping the knee implant ecosystem by improving imaging assessment, surgical planning, implant sizing, alignment prediction, and post-operative monitoring. AI-enabled analytics can help identify patient-specific risks such as infection, readmission, stiffness, and likelihood of revision, supporting more precise decision-making across the care pathway.

The cumulative impact is strongest when AI is integrated with robotics, navigation, registry data, and remote rehabilitation tools. However, adoption depends on validated algorithms, transparent clinical evidence, cybersecurity, interoperability with hospital systems, and regulatory compliance. Leaders that treat AI as a clinical governance tool rather than a stand-alone feature will be better placed to support quality, efficiency, and patient-reported outcomes.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, and Australia combine large aging populations with improving orthopedic infrastructure. Japan and Australia benefit from mature arthroplasty practices and registry-led quality monitoring, while China and India offer significant procedure growth potential as access to joint replacement broadens beyond major metropolitan centers. The region also reflects a wide reimbursement spectrum, making both premium robotic-assisted knee replacement solutions and cost-conscious implant portfolios strategically relevant.

North America remains one of the most established knee implant regions, supported by high procedural volumes, advanced hospital networks, ambulatory surgery adoption, and strong uptake of robotics and digital planning. Europe is characterized by universal or publicly funded healthcare systems, stringent procurement, and extensive registry evidence, with countries emphasizing revision reduction, implant traceability, and health technology assessment. Latin America shows gradual advancement led by Brazil and Mexico amid uneven reimbursement and access, while the Middle East is investing in specialty hospitals and medical tourism hubs, particularly in GCC countries. Africa remains underpenetrated but has long-term potential as surgical capacity, specialist training, trauma care, and orthopedic infrastructure improve.

Key Group Insights

ASEAN presents a mixed but promising knee implant opportunity, with Singapore, Thailand, and Malaysia offering stronger private-sector access and medical tourism capabilities, while Indonesia, Vietnam, and the Philippines represent longer-term demand as healthcare coverage and orthopedic capacity expand. Growth across ASEAN depends on affordability, surgeon training, implant availability, rehabilitation infrastructure, and distribution resilience.

The GCC is supported by healthcare investment, high obesity and diabetes prevalence, and demand for advanced orthopedic services, while the European Union emphasizes evidence-based procurement, CE-marked innovation, medical device regulation, and registry-informed outcomes. BRICS markets combine major population scale with wide access variation, making tiered portfolios, local training, and adaptable pricing important. G7 countries remain innovation leaders because of mature reimbursement, strong clinical research, aging populations, and early adoption of robotics and digital health, whereas NATO markets overlap significantly with Europe and North America and often prioritize supply-chain resilience, regulatory compliance, and continuity of essential medical technologies.

Key Country Insights

The United States leads in procedure volume, innovation adoption, ambulatory joint replacement, and robotic-assisted knee arthroplasty, while Canada's publicly funded system emphasizes wait-time management, cost effectiveness, equitable access, and clinical standardization. Mexico benefits from private hospital growth and cross-border care, while Brazil is Latin America's largest orthopedic opportunity with demand concentrated in major urban centers and shaped by disparities between public and private care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain represent mature knee implant markets where joint registries, reimbursement controls, hospital procurement, and health technology assessment shape adoption. Russia has long-term demand tied to aging demographics but faces supply, access, and procurement constraints. China and India offer the largest volume potential in Asia as osteoarthritis burden rises and specialist access improves, while Japan and South Korea emphasize advanced surgical quality, aging-population care, and technology adoption. Australia benefits from transparent registry evidence, high arthroplasty expertise, and established quality monitoring that continues to influence implant selection and revision performance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated implant systems, registry-compatible data collection, and surgeon education programs that demonstrate lower revision risk and stronger patient-reported outcomes. Building evidence across diverse patient groups is essential as younger, heavier, and more active patients increasingly seek durable knee reconstruction and faster return to function.

Companies should also align portfolios with site-of-care shifts by supporting ambulatory surgery centers, digital planning, rapid recovery pathways, remote monitoring, and value-based contracting. In emerging markets, success depends on affordable implant tiers, reliable local distribution, training partnerships, compliant service models, and procedural support that reduces variability across hospitals and surgeons.

Research Methodology

This executive summary is built on secondary research from public health agencies, orthopedic registries, regulatory bodies, peer-reviewed literature, hospital utilization trends, reimbursement references, and medical device regulatory resources. Sources commonly used for validation include the World Health Organization, national joint registries, the U.S. FDA, European regulatory resources, OECD health data, and orthopedic society publications.

The methodology emphasizes triangulation across epidemiology, procedure demand, technology adoption, reimbursement structures, regional healthcare capacity, regulatory pathways, and competitive positioning. Insights are synthesized to support strategic decision-making without relying on unverified market-size claims, market share statements, or unsupported growth assumptions.

Conclusion

The knee implant market is evolving from traditional joint replacement toward data-driven, personalized, and value-based orthopedic care. Aging populations and the high prevalence of knee osteoarthritis provide durable demand, while robotics, AI, advanced materials, and registry evidence are redefining competitive advantage across total knee arthroplasty, partial knee replacement, and revision procedures.

Future progress will depend on balancing innovation with affordability, access, regulatory compliance, and demonstrable outcomes. Organizations that combine long-term implant performance, procedural efficiency, digital intelligence, surgeon enablement, and regional adaptability will be best positioned to lead the next phase of knee arthroplasty.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Knee Implant Market, by Procedure Type

• 7.1. Total Knee Replacement (TKR)
• 7.2. Partial Knee Replacement (Unicompartmental)
• 7.3. Revision Knee Replacement

8. Knee Implant Market, by Implant Type

• 8.1. Fixed-bearing implants
• 8.2. Mobile-bearing implants
• 8.3. Medial pivot implants

9. Knee Implant Market, by Fixation Method

• 9.1. Cemented
• 9.2. Cementless
• 9.3. Hybrid

10. Knee Implant Market, by Material

• 10.1. Ceramic On Plastic
• 10.2. Metal On Metal
• 10.3. Metal On Plastic

11. Knee Implant Market, by Technology

• 11.1. Computer-assisted surgery (CAS)
• 11.2. Conventional surgery
• 11.3. Robotic Assisted
  • 11.3.1. Fully Automated
  • 11.3.2. Semi-Automated

12. Knee Implant Market, by End User

• 12.1. Hospitals
• 12.2. Specialty Orthopedic Centers
• 12.3. Ambulatory Surgical Centers

13. Knee Implant Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Knee Implant Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Knee Implant Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Amplitude Surgical SA
• 17.2. Arthrex, Inc
• 17.3. B. Braun Melsungen AG
• 17.4. Beijing AK Medical Co., Ltd.
• 17.5. ConforMIS, Inc.
• 17.6. Corin Group plc
• 17.7. DJO, LLC
• 17.8. Elite Surgical Ltd.
• 17.9. Evolutis India Pvt. Ltd.
• 17.10. Exactech, Inc.
• 17.11. FH Orthopedics SAS
• 17.12. LimaCorporate S.p.A.
• 17.13. Medacta International SA
• 17.14. Medical Device Business Services, Inc.
• 17.15. Meril Life Science
• 17.16. MicroPort Scientific Corporation
• 17.17. OMNIlife science, Inc.
• 17.18. Peter Brehm GmbH
• 17.19. Smith & Nephew plc
• 17.20. Stryker Corporation
• 17.21. Surgival Co., S.A.
• 17.22. Waldemar Link GmbH & Co. KG
• 17.23. Zimmer Biomet Holdings, Inc.